Internal Medicine, Endocrinology, Diabetes, & Metabolism · New York, NY
NPI
1639140437
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
215 E 68th St, Suite 8
New York, NY, 10065
Phone (212) 288-2869
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.9M
3,557 prescriptions
Company payments, 2025
$2,526
From 29 companies
Medicare prescription drug claims, 2024
In 2024, the drug Andrew J Martorella prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 486 prescriptions and refills. In total Andrew J Martorella wrote 3,557 Medicare prescriptions that cost $1.9M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-09-22.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Mounjaro Tirzepatide | 486 | 526 | 67 | $539K |
| Ozempic Semaglutide | 442 | 493 | 69 | $454K |
| Synthroid Levothyroxine Sodium | 339 | 801 | 82 | $36K |
| Glimepiride Generic | 119 | 247 | 29 | $1,527 |
| Metformin Hcl Generic | 112 | 282 | 28 | $1,414 |
| Jardiance Empagliflozin | 93 | 161 | 20 | $94K |
| Levothyroxine Sodium Generic | 93 | 247 | 27 | $1,121 |
| Trulicity Dulaglutide | 79 | 88 | 11 | $82K |
| Prolia Denosumab | 67 | 399 | 36 | $117K |
| Janumet Xr Sitagliptin Phos/Metformin Hcl | 62 | 100 | Under 11 | $35K |
| Hydrocortisone Generic | 58 | 100 | Under 11 | $2,287 |
| Atorvastatin Calcium Generic | 50 | 138 | 14 | $593 |
| Xyosted Testosterone Enanthate | 46 | 48 | Under 11 | $29K |
| Cytomel Liothyronine Sodium | 44 | 70 | Under 11 | $1,907 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 43 | 108 | 17 | $3,590 |
Brand drugs: 2,279 claims; generic drugs: 1,140 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andrew J Martorella $2,526 ($2,526 in general payments such as food, travel and fees) from 29 companies. The largest payer was Amgen Inc. with $481.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 14 | $481 |
| Abbvie Inc. ABBV | 16 | $255 |
| Lilly USA, LLC LLY | 11 | $227 |
| Beta Bionics, Inc. BBNX | 4 | $198 |
| Novo Nordisk Inc NVO | 9 | $160 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $122 |
| Pfizer Inc. PFE | 5 | $110 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $108 |
| Sanofi-Aventis U.S. LLC SNY | 6 | $105 |
| Corcept Therapeutics CORT | 4 | $80.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.